“This novel approach may help alleviate the burden often associated with daily, oral treatment regimens and contribute to making HIV a smaller part of peoples’ lives.”
“The approval of the first single dose two-drug regimen for HIV challenges the traditional approach of three-drug regimens that have been the standard of care for 20 years.”
The Bobby Goldsmith Foundation has partnered with For Benefit Medicines, Australia’s first pharmaceutical company which donates profits to medical research and patient support.
“While we talk about ‘game-changers’ in terms of bio-medical or pharmaceutical solutions, the real game changer is the positive person.”
HIV organisations with creative ideas could be the recipient of a share in $180,000 in funding.
Living Positive Victoria CEO Brent Allan was pleased with ADF’s swift response.